MT-2412

· Tanabe Pharma Corporation

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MT-2412, covering 2018-08-16 to 2018-08-16. Get the full timeline:

Most recent: Clinical Trial Update: Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin) [Phase 3]